In Vivo Pharmacological Resultant Analysis Reveals Noncompetitive Interactions Between Opioid Antagonists in the Rat Tail-withdrawal Assay.
From: Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA. ellen.walker@temple.edu
British journal of pharmacology
- Publish Date: Dec 2006
- ISSN: 0007-1188
- Volume: 149
- Issue: 8
- Pages: 1071-82
- Medium: Print
- Language: English
- Citation (JAMA): Walker E A, et al. In Vivo Pharmacological Resultant Analysis Reveals Noncompetitive Interactions Between Opioid Antagonists in the Rat Tail-withdrawal Assay.. Br. J. Pharmacol. Dec 2006;149:1071-82
Abstract
BACKGROUND AND PURPOSE: Pharmacological resultant analysis is a technique that can detect secondary effects of competitive antagonists in vitro. The utility of pharmacological resultant analysis as a potential tool for the investigation of antagonist interactions in vivo was examined in the present study using two opioid antagonists, naltrexone and CTAP. EXPERIMENTAL APPROACH: Using the experimental design of pharmacological resultant analysis, the well-characterized opioid antagonist naltrexone was examined in the presence of multiple doses of CTAP to block the antinociceptive effects of morphine in the rat warm-water (55(o)C), tail-withdrawal assay. KEY RESULTS: Alone, all doses of naltrexone, CTAP, and CTOP examined blocked the antinociceptive effects of morphine. In the presence of fixed doses of 1 or 10 microg CTAP, increasing doses of naltrexone produced dose-dependent shifts to the right in the morphine dose-response curve. However, a lower dose of naltrexone in combination with 1 or 10 mug CTAP failed to alter the morphine dose-response curve. In the presence of a fixed dose of 0.1 mg kg(-1) naltrexone, CTAP doses produced irregular shifts to the right in the morphine dose-response curves. CONCLUSIONS AND IMPLICATIONS: Resultant analysis was applied and an apparent pK(C) value for CTAP was found to be one log unit higher than the apparent pA(2) value for CTAP, evidence that CTAP may have secondary actions or that a signal transducer function may be altered by the combinations of these antagonists. Taken together, these data suggest pharmacological resultant analysis can reveal novel interactions between antagonists in vivo.
Mesh Headings (Keywords): Algorithms, Animals, Dose-Response Relationship, Drug, Drug Interactions, Injections, Intraventricular, Injections, Subcutaneous, Male, Morphine, Naltrexone, Narcotic Antagonists, Narcotics, Pain Measurement, Peptides, Rats, Rats, Sprague-Dawley, Reaction Time, Somatostatin
Check for Full Text / PubMed Unique Identifier (PMID): 17075571
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.